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Studies of renal autoregulation in pancreatectomized and streptozo-
tocin diabetic rats. We studied renal autoregulation in pancreatecto-
mized Munich-Wistar diabetic rats and in their sham-operated controls.
In a second experiment we studied renal autoregulation in untreated
and insulin treated streptozotocin diabetic Munich-Wistar rats and their
nondiabetic controls. In the first experiment the diabetic rats had higher
baseline renal blood flows (RBF). There was a fall in renal vascular
resistance (RVR) and sustained RBF in both diabetic and control rats as
renal perfusion pressures (RPP) was reduced from 130 and 110 mm Hg.
As RPP was reduced from 110 and 80 mm Hg, there was no significant
change in RVR in control rats and RBF began to fall. Below RPP of 80
mm Hg RVR rose and RBF fell sharply in these rats. In contrast, there
was a progressive fall in RVR as RPP was lowered to 60 mm Hg in the
diabetic rats and, thus, RBF was much better sustained in these
animals. In the second experiment the plasma glucose level was 502
52 mg/dl (X SD) in the untreated diabetic rats and only modestly
reduced to 411 49 mg/dl in the insulin treated animals. Untreated
streptozotocin diabetic rats had moderately reduced and insulin-treated
diabetic rats had mildly reduced baseline RVR and RBF. However, in
these animals as in the pancreatectomized rats the increases in RVR
noted in control rats at subautoregulatory RPPs were not seen. Thus,
regardless of whether baseline RBFs were increased or decreased,
diabetic rats sustained RBF at markedly reduced RPPs far more
efficiently than did nondiabetic rats. The pathogenesis of these abnor-
malities in diabetic rats was not learned in these studies. However, it is
likely that further study of autoregulation in diabetic rats could uncover
factors influencing renal vascular tone which would be helpful in
understanding the renal hemodynamic perturbations which may attend
this experimental model.
Many juvenile onset diabetic patients have large kidneys and
elevated glomerular filtration rates (GFR) and renal blood flow
(RBF) very early in the disease [1]. Similar findings may be
present in moderately diabetic animals [2—5]. Furthermore,
some [2] but not all [4] strains of moderately diabetic rats have
elevated glomerular capillary pressures, although severely dia-
betic rats have normal or reduced glomerular capillary pres-
sures and flows [2, 4, 6]. It has been suggested that perturba-
tions in glomerular hemodynamics might influence the rate of
development of renal injury in diabetes [2, 7, 81, although
effects of these functional perturbations on rates of glomerular
basement membrane widening or on fractional mesangial vol-
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ume increases have not yet been documented in animals or
man.
Since GFR and RBF are independent of renal perfusion
pressure (RPP) over the autoregulatory range [9], we wanted to
know if, in the early diabetic state, the renal perfusion pressure-
blood flow relationship was altered.
Methods
Two noncontemporaneous studies were performed. In the
first (Experiment I) Munich-Wistar rats were made diabetic by
subtotal pancreatectomy while in the second (Experiment II)
streptozotocin was used to induce diabetes in this same strain of
rats.
Experiment I
The subtotal pancreatectomy model of Foglia, Mancini and
Cardeza [10] was used. Fifteen male Munich-Wistar rats (Si-
monsen, California, USA) weighing approximately 250 g were
anesthetized with an intraperitoneal injection of 50 mg/kg/body
weight of Brevital. Six of these rats underwent subtotal pancre-
atectomies (95 to 98% pancreatic tissue removal) and splenec-
tomies. The latter was done to shorten the time of surgery.
Eight age and weight matched (± 10 g) rats received a sham
operation, which included splenectomies. After the surgery, the
animals were returned to individual cages and fed a liquid diet
for 48 hours. Thereafter, they received Purina lab chow diet and
water ad libitum. Animals were tested daily for urinary glucose
to confirm the onset of diabetes mellitus, and they were
weighed once a week. Food intake was not measured.
Experiments were performed two to six weeks after the
appearance of the glycosuria which generally was first seen
from 15 to 30 days post-pancreatectomy. Since all animals did
not develop glycosuria at the same time, a successful experi-
ment on a diabetic (D) rat was followed by an experiment on an
age-matched sham operated control (C) rat. In the group of
diabetic rats reported herein plasma glucose levels were not
measured except at the end of the renal physiologic studies and,
thus, these were not considered representative. These plasma
glucose levels were 616 18 mg/dl (X SD). However, in 16
rats prepared in parallel to those presented here non-fasting
plasma glucose levels were 379 99 mg/dl (X SD) in
unmanipulated animals as compared to 137 7 mg/dl in 19
control animals. Rats were allowed free access to food and
water prior to experimentation.
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Table 1A. Model characteristics in experiment I in subtotal pancreatectomized diabetic and sham control rats
Body Kidney Kidney wt/
wt wt body wt
g ratio
HCT
%
AP
mm Hg
RBF
mI/mm/rat
RVR
mm Hg/mi/mm
Diabetics 251 7 2.8 0.2 0.0056 49 1.5 129 5 10.4 0.7 12 0.7
N= 6
Controls 283 8 2.4 0,1 0.0042 49 0.6 144 3 8.6 0.6 17 1.2N=8
2P values <0.025 NS NS NS <0.05 NS <0.001
Abbreviations are: Body wt, body weight; Kidney wt, weight of kidney per rat; HCT, hematocrit; AP, arterial pressure; RBF, renal blood flow,
RVR, renal vascular resistance; N number of animals studied.
Experiment II
Male Munich-Wistar rats (Bioproducts Division of Harlan
Sprague-Dawley, Madison, Wisconsin, USA) aged 50 days and
weighing 100 to 120 g were made diabetic by the intravenous
injection of 65 to 70 mg/kg of streptozotocin (supplied by
Upjohn Corp., Kalamazoo, Michigan, USA) prepared in citrate
buffer, pH 4.0. Diabetes was confirmed by the development of
nonfasting plasma glucose levels exceeding 400 mg/dl. These
levels were determined by the glucose oxidase method on a
Beckman Glucose Analyzer (Beckman Instruments Inc., Ful-
lerton, California, USA).
Two groups of diabetic rats were studied. The first group (D)
was untreated with insulin (N 7). The second group (D + I,
N = 11) received a special heat treated, long-acting ultra lente
insulin (supplied by Novo Industry, Copenhagen, Denmark) in
a daily dose of 0.3 to 1.4 IU (0.94 0.32) given at 3:00 to 5:00
p.m. Plasma glucose levels to monitor the insulin treatment
were obtained at 8:00 to 11:00a.m. When the insulin dose was
stabilized, glucose levels were measured every other day. The
aim was to maintain plasma glucose levels at approximately 350
mg/dl, and this was generally achieved. The glucose levels
presented in Results (Table 1B) are from unmanipulated animals
just prior to the autoregulatory studies. Eight littermates served
as controls.
All rats were also given free access to water and to standard
Purina rat chow. Food intake was measured in rats individually
housed for two consecutive days. Daily food intakes were
recorded and the average intake for the two days calculated.
Kidney physiology studies
Renal function studies were performed six to eight weeks
after induction of diabetes in Experiment II and as noted above
in Experiment I. On the day of these studies, animals were
anesthetized with intraperitoneal mactin (80 mg/kg body wt).
Animals were placed on a temperature-regulated micropuncture
table. A tracheostomy was performed. Urine flow was moni-
tored through a bladder catheter. In Experiment I a solution of
1/3 plasma (obtained from littermates) to 2/3 Krebs-Henseleit
solution was infused via a femoral vein catheter at a rate of 5
mi/hr for 30 minutes, thereafter the rate was reduced to 1.2
mi/hr. In Experiment II rats were infused via an external jugular
vein with 5% bovine serum albumin, 0.5% of body weight over
20 minutes. This was followed by a bolus of 0.5 ml of a mixture
of 6.6 j.Ci of methoxy 3H-inulin (ICN Radiochemicals Division
of ICN Biomedicals, Inc., Irvine, California, USA) diluted 1:1
in Ringers solution over 10 minutes followed by a constant
infusion of the same mixture at a rate of 1.2 mi/hr.
In Experiment II two 30-minute urine collections were ob-
tained for the measurement of GFR following a 30-minute
equilibration period, and blood samples were withdrawn from
the femoral artery catheter at the midpoint of these collection
periods. GFR was not measured in Experiment I.
In both experiments femoral arterial pressure (AP) was
considered as the renal perfusion pressure (RPP) and was
monitored with a Statham P23 Db pressure transducer (Statham
Instruments, Los Angeles, California, USA) connected to a
Beckman Dynograph (Beckman Instruments). The left kidney
and the aorta were exposed through a midline and left lateral
abdominal incision and the left renal artery was dissected with
special care in avoiding disturbance of the renal nerves.
Blood flow in the left renal artery was measured continuously
by a small diameter flow probe (1.5 or 1.8 mm circumference
lumen size) connected to a square wave electromagnetic flow-
meter (Model 501, Carolina Medical Electronics, King, North
Carolina, USA) and a Beckman Dynograph. The flow probe and
flowmeter were calibrated using an in vitro technique [9]. The
electronic zero of the flowmeter system was calibrated in vitro
and in vivo. Absolute zero flow through the renal artery was
determined at the end of the experiment. Positioning of the flow
probe around the renal artery was judged acceptable when there
was a snug fit and the pulsatile flow recorded was free from
mechanical "noise". After 15 minute equilibration, baseline
values for hematocrit (Hct), renal blood flow (RBF) and arterial
pressure (AP) were obtained for 15 minutes. Thereafter, the
relationship of RBF to AP was studied over a pressure range
from 140 to 50 mm Hg.
Progressive decrements in AP of approximately 10 mm Hg
were achieved and maintained at a stable level (± 3.5 mm Hg)
by using a constrictor clamp around the aorta above the renal
arteries. The degree of aortic constriction was obtained manu-
ally through a knob connected to a tube filled with distilled
water. The pressure exerted by the hydraulic column de-
scended the plate of the aortic clamp. This device allowed for
adjustment of renal perfusion pressure without disturbing the
animal. Each level of perfusion pressure was maintained for 3
minutes. When the 50 mm Hg pressure period ended, the aortic
constrictor was slowly released and AP was allowed to return to
basal levels.
After a 15-minute equilibration period, Hct, RBF, and AP
were again obtained for a period of 15 minutes and a new
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pressure-flow curve performed. At the end of this curve, AP
and RBF were allowed to return to baseline for 10 minutes
before occluding the renal artery to obtain the absolute zero
flow 0.5 ml. Experiments that had greater deviations were not
used. Finally, the kidney was removed and weighed and blood
samples were obtained for Hct determinations.
Seventy-seven percent of the physiology experiments were
successfully completed. Experiments failed because the main
renal artery branched too close to the aorta to allow probe
placement, instability of systemic blood pressure, low urine
flow during GFR measurements, or failure of the hematocrit to
remain stable. There was no tendency for experimental failure
to cluster in any of the animal groups.
Calculations
Intrarenal vascular resistance (RVR) was calculated from the
arterial venous pressure difference and blood flow. Renal
venous pressure was assumed to be constant and assigned a
value of 5 mm Hg in the calculations [91. Thus,
RPP - 5 mm Hg.RVR = in mm Hg/ml/minRBF
based on total RBF assuming equal RBF in both kidneys
RPFRBF = in mi/mm
(1 — Hct)
FF=
RPF
where FF = filtration fraction.
To compare the efficiency of autoregulation among the
groups studied, the autoregulation factor was calculated as
RBF2—RBF1 /RPP2—RPPI
RBF1 / RPP1
where RPP1 and RPP2 are selected perfusion pressures and
RBF1 and RBF2 are the respective measured flow rates at the
given perfusion pressures [11, 12]. A value of 1 indicates
absence of autoregulation while a ratio of less than I indicates
presence of autoregulation. RBF1 equal to RBF, indicates
perfect autoregulation.
Curvilinear relationships between variables were fitted with a
polynomial equation (order of three). The value of the indepen-
dent variable when the independent variable reached a maxi-
mum or minimum (inflexion or break point) was determined in
two different ways: by repeated calculations of the equation and
variation of the independent variable and by calculating the
value of the independent variable when the first derivative of
the polynomial was equal to zero.
Statistical analyses
The autoregulatory factor for a given range of RPP was
compared between groups by a two-tailed Student's (-test for
unpaired data. Comparisons of different ranges of RPP within a
group was done by Student's 1-test for paired data. Linear
regression analysis was done by the method of least squares. A
value of 2P < 0.05 was considered statistically significant.
However, due to the number of statistical comparisons made,
caution should be used in interpreting values for 2P between
0.01 and 0.05.
Results
Model characteristics—Experiment I
Body weights in diabetics were about 11% lower than in sham
operated controls (2P < 0.025). The mean 17% increase in
kidney weight and the increased kidney wt/body wt of diabetics
did not reach statistical significance (Table 1A). AP was about
15 mm Hg lower in diabetic animals (P < 0.05). Hct values were
similar. The average basal levels of RBF was not different
between diabetic and sham rats but RBF/100 g body wt was
significantly higher in diabetic rats. Renal vascular resistance
was decreased by 42% in diabetic rats (P < 0.001).
Model characteristics—Experiment II
Rats with untreated diabetes had severe hyperglycemia (502
52mgldl) which was only modestly ameliorated by the insulin
treatment (411 49 mgldl, 2P <0.0002, Table 1B). Food intake
after two weeks of diabetes increased by about 54% in un-
treated diabetic and insulin treated diabetic rats compared to
controls (P <0.03 for each comparison). Food intake after eight
weeks of diabetes was about 63% greater in both untreated and
treated diabetic rats compared to controls (2P <0.0001 for each
comparison). There were no differences in food intake at any
time comparing untreated and insulin treated diabetic rats.
Body wt at eight weeks was lowest in untreated diabetic rats
(66% of control body wt, 2P <0.001) but was still reduced in
insulin treated rats (81% of controls, 2P < 0.002). Kidney
wt/body wt were increased by about 50% in both groups of
diabetic rats compared to controls (Table 1B) but were not
significantly different when untreated and insulin treated rats
were compared. There were no significant differences in base-
line Hct among any of the groups. Severely diabetic but not
insulin treated diabetic rats had reduced AP compared to
controls at baseline (Table 1B). GFR was reduced by 32% in
severely diabetic rats compared to controls (2P < 0.04) and by
16% in insulin treated rats (2P <0.04, Table lB). GFR was 16%
higher in insulin treated compared to untreated diabetic rats (2P
<0.002). GFR per 100 g body weight was similar in all three
groups. RBF was lowest in severely diabetic rats and highest in
control rats but, again, based on body weight, was not different
between the three groups (Table 1B). Baseline RVR was highest
in the severely diabetic group and lowest in the controls (Table
1B) while filtration fraction was not different among these
groups of rats.
Autoregulation studies—Experiment I
Renal blood flow (RBF) at 120 mm Hg perfusion pressure
(RPP) was higher in the diabetic rats and remained higher
through the stepwise reduction in RPP to 50 mm Hg compared
to controls (Fig. 1). The break point for autoregulation in the
control animals occurred at 100 mm Hg RPP. Although there
was no clear break point in the diabetic rats, the best estimate
for this was between 50 and 60 mm Hg RPP (Fig. 1). Expressed
as a percent of flow at 120 mm Hg the RBFs were greater in
diabetic rats at RPPs below 110 mm Hg, and these differences
increased in magnitude as RPP was further reduced (Fig. 2).
RVR initially fell in both groups but began to increase in
controls at RPP below 70 mm Hg while continuing to decrease
in the diabetic rats (Fig. 3).
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Table HI. Model characteristics in experiment II in streptozotocin insulin treated and untreated diabetic rats and in controls
Glucose
mg/dl
Body wt Kidney Wt Kidney wt/
body wt ratio
HCT
%
AP
mm Hg
GFR/kidney
mi/mm
GFRlkidney
m!/lOO g body wtg
Untreated 502 52 186 31 1.2 0,2 0.0066 0.0005 0.48 0.02 115 7 0.75 0.05 0.84 0.1
diabetics (D)
N= 7
Insulin treated 411 49 229 24 1.3 0.1 0.0058 0.0005 0.47 0.02 125 12 0.96 0.15 0.85 0.1
diabetics
(D + I)N=ll
Controls (C) 123 9 281 37 1.0 0.1 0.0035 0.0005 0.49 0.02 129 7 1.1 0.15 0.79 0.1
N= 8
2P values
D vs. C 0.0001 0.0001 0.002 0.02 NS 0.002 0.04 NS
D + I vs. C 0.0001 0.0002 0.0001 0.0001 NS NS 0.04 NS
D vs. D + I 0.0002 0.004 NS NS NS NS 0.002 NS
Abbreviations are: Body wt, body weight; Kidney wt, weight of a single kidney; HCT, hematocrit; AP, arterial pressure; GFR, glomerular
filtration rate; RBF, renal blood flow; RVR, renal vascular resistance; FF = ifitration fraction; NS = not significant.
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Fig. 1. Renal blood flows at varying renal perfusion pressures in
pancreatectomized diabetic (D, —•—) and sham operated control (C,
—--0--—) animals in Experiment I. * = significant difference between D
and C.
Calculations of the autoregulation factor for RPP 90 to 120
mm Hg indicated that autoregulation was more efficient in
diabetic rats (2P < 0.005). Autoregulation factor was not
different from unity or from each other in diabetic and control
rats for RPP 60 to 90 mm Hg (Fig. 4).
Autoregulation studies—Experiment II
In this experiment RBF was lower in untreated diabetic rats
compared to controls at 110 mm Hg, with intermediate values in
the insulin treated rats. In control rats the break point in the
autoregulatory curve appeared at 115 mm Hg while both
diabetic groups continued to sustain their respective basal
RBFs below this RPP. Thus, at RPPs of 60 and 50mm Hg, RBF
was now significantly higher in insulin-treated diabetic rats
compared to controls (Fig. 5). Expressed as percent of RBF at
110 mm Hg, the values were higher in the treated and untreated
diabetic rats compared to the control rats at all RPP below 110
mm Hg, except at 90 mm Hg where insulin treated diabetics
were not significantly different from controls (Fig. 6).
RVRs were initially significantly higher in untreated diabetic
rats compared to controls at all RPP between 100 and 80 mm Hg
(Fig. 7). However, below RPRs of 95 mm Hg RVR began to rise
in controls while still falling in the untreated diabetic rats, so
that at RPPs of 60 and 50 mm Hg RVRs tended to be higher than
in the controls. Similarly, RVR was higher in insulin treated
diabetics compared to controls at 120, 110, and 100 mm Hg
RPPs, and significantly lower than controls at RPPs of 60 mm
Hg RPR (P < 0.04) and 50 mm Hg RPP (2P = 0.04, Fig. 7).
Autoregulation was significantly more efficient between the
RPPs of 90 to 110 mm Hg for severely diabetic rats compared to
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Fig. 2. Renal blood flows at varying renal perfusion pressures ex-
pressed as a percent of the flow at 120 mm Hg in pancreatectomized
diabetic (D, —•—) and sham operated control (C, ——0——) animals in
Experiment J * = significant difference between D and C.
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Fig. 3. Renal vascular resistances at varying renal perfusion pressures
in pancreatectomized diabetic (D, ——) and sham operated control (C,
——0——) animals in Experiment 1. * = significant difference between D
and C.
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controls (2P < 0.005) and showed a similar tendency for
insulin-treated diabetic rats (P < 0.08). The autoregulation
factor for RPP 60 to 90 mm Hg in control rats was greater than
unity and greater than that in severely diabetic rats (P < 0.003)
and insulin-treated diabetic rats (2P < 0.001; Fig. 8).
Discussion
These studies show that the renal hemodynamic responses to
graded reduction in renal perfusion pressure are markedly
different in diabetic as compared to control rats. The results
indicate that regardless of whether baseline renal blood flow is
increased or decreased in the diabetic animals, renal blood flow
was remarkably sustained in association with progressive dec-
rements in renal vascular resistance. In contrast, renal vascular
resistance initially declined in nondiabetic rats, then became
level and finally, at perfusion pressures below 80 mm Hg, began
to rise sharply. This pattern of response to reductions in renal
perfusion pressure in normal rats, including the variability in
the onset and magnitude of the increase in renal vascular
resistance at low perfusion pressures, has been seen in numer-
ous studies [9, 11, 13—171. However, the diabetic pattern of
response in which the progressive increase in RVR in the lower
range of subautoregulatory pressures fails to occur has not been
previously described except in young rats treated with prosta-
glandin inhibitors [16] and in salt depleted rats treated with
either saralasin or captopril or with kinin infusion [18J.
As expected [2, 7], body weights were reduced in the diabetic
animals, most severely in untreated streptozotocin diabetic
Table lB. Continued
RBF/kidney
RBF/kidney ml/min/100 g RVR
mI/mm body wt mm Hg/mI/mm FF
4.8 0.6 2.6 23.2 2.1 0.33 0.05
6.2 0.7 2.7 19.9 3.1 0.31 0.02
7.7 1.1 2.8 16.3 2.3 0.29 0.03
0.0001 NS 0.0001 NS
0.001 NS 0.014 NS
0.002 NS 0.028 NS
20.
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Fig. 4. Autoregulation factor results in Experiment I in pancreatecto-
mized diabetic (D, VA) and sham operated control (C, •) animals.
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Fig. 5. Renal blood flows at varying renal perfusion pressures in
untreated diabetic (D, —•—), insulin treated diabetic (D + I, ——El——)
and control (C, ——0——) animals in Experiment II. * = significant
difference between D and C; v = significant difference between D + I
and C; El = significant difference between D and D + I.
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[61 or decreased [61 GFR and RBF. Baseline arterial blood
pressures were lower in the severely diabetic rats in both
studies, this confirming observations we have made with an-
other strain of diabetic rats [6].
The two models of diabetes, subtotal pancreatectomy in
which islet mass is markedly reduced and streptozotocin in-
duced diabetes in which pancreatic islet cells are spared but for
specific /3-cell destruction [231, resulted in different renal hemo-
dynamic outcomes. Thus, pancreatectomized rats, a model
which in our hands produces moderate hyperglycemia, had
increased renal blood flow at baseline renal perfusion pressure.
In contrast, streptozotocin diabetic rats had lower baseline
renal blood flows and glomerular filtration rates than controls,
although insulin treated compared to untreated streptozotocin
diabetic rats had higher values for these parameters. These
animals had higher plasma glucose levels than generally seen in
our pancreatectomy model. Similar results for baseline renal
hemodynamic measures have been reported by several groups
of investigators [2, 4, 7, 8, 24—26]. Generally, moderately
diabetic rats with lower values for plasma glucose levels than
achieved in the insulin-treated diabetic rats in the current study
have increased renal blood flow and GFR. Some [2, 26] but not
all [4, 24] strains of moderately diabetic rats also have increased
glomerular capillary pressures. Thus, the severity of the dia-
betic state in the insulin-treated streptozotocin animals in the
present studies may explain why renal hyperperfusion and
hyperfiltration were not seen. It is also possible that the
differences in baseline renal blood flow in the pancreatectomy
versus streptozotocin diabetic models represents residual neph-
rotoxic effects of streptozotocin. However, these influences
have been reported to be short lived [27]. Attributing these
differences in renal hemodynamics to depletion or preservation
of pancreatic islet cell types other than /3-cells or to differences
in pancreatic exocrine function would be highly speculative but
would be deserving of further study if the observations reported
here can be confirmed.
However, regardless of whether the baseline levels of RBF in
the various groups of diabetic rats were increased or decreased,
the responses to graded reductions in RPP were consistent
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140 Fig. 8. Autoregularion factor results in Experiment II in untreateddiabetic (D, ), insulin treated diabetic (D + 1, 0) and control (C, •)
animals.
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Fig. 6. Renal blood flows at varying renal perfusion pressures ex-
pressed as a percent of the flow at 110mm Hg in untreated diabetic (D,
—•—), insulin treated diabetic (D + I, LJ") and control (C, ——0——)
animals in Experiment II. * = significant difference between D and C;
A = significant difference between D + I and C.
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Fig. 7. Renal vascular resistances at varying renal perfusion pressures
in untreated diabetic (D, —*—), insulin treated diabetic (D + I, ——D——)
and control (C, —--0——) animals in Experiment II. * = significant
difference between D and C; A = significant difference between D + I
and C; 0 = significant difference between D and D + I.
rats. However, all were in positive nitrogen balance as indi-
cated by increased body weight over time since induction of
diabetes. Increased kidney weight to body weight ratios have
been previously described in diabetic rats [6] as has increased
absolute kidney size in animals [6, 19, 20] and in type I diabetes
in man [1]. However, accelerated renal growth antedates mea-
sureable renal hernodynamic changes following induction of
diabetes in rats [21] and occurs with increased [2, 22], normal
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between the groups and strikingly different from the responses
of the control rats. While all groups of rats evidenced autoreg-
ulation of blood flow at RPPs above 100 to 110 mm Hg, further
reductions in RPP resulted in greater decreases in RBF in the
control as compared to the diabetic groups. Conversely,
whether the baseline measures of RVRs were higher (pancre-
atectomy model) or lower (streptozotocin model) than the
respective controls, the patterns of change in RVR with pro-
gressive lowering of RPP were similar between the diabetic
groups and different from the controls. The control groups had
an initial fall in RVR as RPP was reduced towards 100 mm Hg.
RVR then became level between RPPs of 110 to 80 mm Hg and
rose thereafter. The RVRs in the three diabetic groups became
level below 70 mm Hg and did not rise. We can conclude that
whatever factors determined baseline RVR in the diabetic
animals, the presence of or induction of strong vasodilatory
forces or the inability to generate strong vasoconstrictive
forces, or both, resulted in maintenance of RBF in these rats at
extremely low perfusion pressures. Also, diabetic animals with
increased baseline RBF based on decreased RVR can further
decrease RVR and thus do not have maximal renal vasodilata-
tion at baseline.
Several factors known to influence renal vascular tone or
responsiveness may be altered in diabetic rats. Firstly, food and
thus protein intake was increased by about 66% when measured
in the streptozotocin diabetic rats in these studies as we have
previously shown [61. Increased protein intake is known to
increase RBF in normal and diabetic rats [6, 7], probably
through reductions in both afferent and efferent glomerular
arteriolar resistances [6, 7). The mechanism by which protein
intake influences renal vascular resistance is not entirely under-
stood. There are data consistent with increased glomerular
production of vasodilatory prostaglandins in intact and subto-
tally nephrectomized rats maintained on increased (50%) com-
pared to reduced (6%) dietary protein intake [28]. Further,
Paller and Hostetter [29] and Murray [30] have shown that rats
fed 50% as compared to 6% dietary protein have diminished
systemic and renal vasoconstrictor responses to infused anglo-
tensin II, and that these vasoconstrictor responses could be
normalized by prostaglandin synthesis inhibitors but not by
angiotensin converting enzyme inhibitors. However, it is un-
clear whether the 60% increase in protein intake in diabetic
compared to control rats in the present studies could have
effected the differences related to more than eight fold differ-
ence in dietary protein in the above cited experiments [28—30].
Both increased dietary protein intake and diabetes are asso-
ciated with renal hypertrophy in rats [6, 19, 20]. However, renal
hypertrophy, per se, is unlikely to explain the results of the
current study since unilateral nephrectomy in adult rats pro-
duced no changes in the shape of the autoregulatory curve or in
the autoregulation factor [12]. In young intact or uninephrecto-
mized rats prostaglandin inhibition resulted in progressive
decrements in RVR in both the normal and hypertrophied
kidneys at RPP below the normal range, this resulting in
autoregulation curves remarkably similar to those seen in our
diabetic rats [16]. Chevalier, Carey and Kaiser concluded from
these results that prostaglandin-dependent renin release is
important in increasing RVR at RPP below 70 mm Hg in these
young rats [16]. In older rats, however, inhibition of prostaglan-
dins did not influence the autoregulatory response [16]. What-
ever the mechanism(s) whereby dietary protein intake might
influence autoregulatory responses, studies in diabetic and
control rats which control for dietary protein intake need to be
done.
As suggested above, alterations in the prostaglandin-renin
angiotensin system could influence renal autoregulation. Indo-
methacin infusion caused increased afferent and efferent gb-
merular arteriolar resistance and decreased transcapillary hy-
draulic pressure and single nephron gbomerular filtration rate in
streptozotocin diabetic rats but had no effect on glomerular
hemodynamics in control rats [25]. Increased perfusate glucose
levels caused a dose dependent vasodilatation and increase in
glomerular filtration rate in isolated perfused kidneys from both
diabetic and normal rats, and these increases could be partially
prevented by prostaglandin synthetase inhibitors [31]. Also,
vasodilatory prostaglandin, but not thromboxane B2, produc-
tion was increased in gbomeruli isolated from untreated strep-
tozotocin diabetic rats but not from diabetic rats rendered
normoglycemic by insulin therapy [32]. Similar findings in aorta
of streptozotocin diabetic rats have been reported [33]. These
alterations in prostaglandin metabolism could act directly on
glomerular arteriolar tone or indirectly through modulation of
renin release from juxtaglomerular cells [34]. In this regard,
despite lower plasma renin concentrations Ballermann, Sko-
recki and Brenner have reported lower glomerular angiotensin
receptor concentrations at low, intermediate or high salt intakes
in untreated diabetic Munich-Wistar rats [35]. These receptor
abnormalities were normalized by insulin treatment which
moderated but did not normalize the hyperglycemia [35]. On the
other hand, Bank et al found that low salt intake normalized the
elevated GFR and RBF of untreated streptozotocin diabetic,
Sprague-Dawley rats and that the effect of this diet could be
reversed by administration of an angiotensin converting en-
zyme inhibitor [36]. Thus, the role of alterations in gbomerular
angiotensin receptors in influencing gbomerular hemodynamics
in diabetic rats is unclear.
Reductions have also been described in the renal synthesis of
kallikrein in diabetic rats [37] and the renal kinins can stimulate
gbomerular mesangial cell [38] and arteriolar [391 eicosinoid
production. Insulin-treated diabetic rats with hyperfiltration
have increased renal and urinary active kallikrein while insulin
untreated, severely diabetic rats with reduced GFR and RBF
have reduced renal and urinary kallikreins [40, 41].
Bank et al also suggested that defective transmembrane
calcium flux across vascular smooth muscle cells could be
responsible for decreased renal vascular resistance in strepto-
zotocin diabetic rats based on findings of reduced GFR and
RBF in hyperfiltering kidneys of these animals infused with
Ca and insulin and the abrogation of this effect by simulta-
neous infusion of the calcium channel blocker verapamil [42].
Hyperglycemia per se could lead to abnormalities of intracellu-
lar calcium transport through stimulation of the aldose reduc-
tase pathway and myo-inositol depletion [43]. Increased plasma
levels of atrial natiuretic peptide have also been implicated in
the hemodynamic abnormalities of insulin-treated diabetic
Munich-Wistar rats [44], but it is difficult to understand how
graded reduction in RPP would influence the blood levels of this
peptide hormone. Blantz and Konnen have shown, in micro-
perfusion studies, that the addition of glucose to late proximal
tubular perfusion fluid blunts the normal single nephron filtra-
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tion rate response to increased distal perfusion rate [45]. Blantz
et a! also demonstrated that microperfusion of glucose-free fluid
in hydropenic rats with hyperglycemia induced by glucose
administration reduced single nephron glomerular filtration rate
(SNGFR) while similarly infused glucose containing proximal
tubular fluid from a hyperglycemic rat failed to change SNGFR
[46]. Thus, glucose can have local effects on glomerular tubular
feedback through mechanisms independent of systemic circu-
latory alterations. A decrease in the sensitivity of the tubulo-
glomerular feedback mechanism was confirmed by Jensen et al
in studies of moderately hyperglycemic streptozotocin diabetic
Wistar rats [47], while Rasch and Holck demonstrated ultra-
structural abnormalities of the macula densa of this rat model
[48], perhaps providing a structural basis for these functional
abnormalities. Woods, Mizelle and Hall showed that glucose
infused into the kidney of normal dogs results in increased GFR
and RBF and decreased RVR at normal RPP. However, reduc-
tions in RPP caused more rapid declines in RBF in these
kidneys than in the normoglycemic controls [49]. These latter
studies suggest that hyperglycemia, per se, may not be an
adequate explanation for the results obtained in our studies.
Finally, as reviewed by Ditzel [50], it has been hypothesized
that abnormalities in tissue oxygenation in diabetes may under-
lie disturbances in microvasculatory autoregulation.
It is apparent that there are complex alterations in the factors
regulating renal vascular tone in the diabetic rat model. These
alterations might be influenced by the mode of induction of
diabetes, the strain of rat studied, the severity of the diabetic
state and the administration of insulin. The basic abnormalities
in renal vascular resistance described in the present studies
occurred with different methods of diabetes induction, whether
or not the animals had increased or decreased RBF at baseline
and whether or not insulin treatment was given. This suggests
that further study of autoregulation in this model could uncover
factors influencing renal vascular tone in diabetic rats that
would be helpful in the understanding of the glomerular hemo-
dynamic perturbations of diabetes.
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